View this step-by-step tutorial on how to administer Panhematin® to a patient with one of the Acute Hepatic Porphyrias - Acute Intermittent Porphyria (AIP), Hereditary Coproporphyria (HCP), Variegate Porphyria (VP) or ALAD Deficient Porphyria (ADP), including dose calculations.
Attacks of Porphyria may progress to a point where irreversible neuronal damage has occurred. Panhematin® therapy is intended to prevent an acute Porphyria attack from reaching the critical stage of neuronal degeneration. Panhematin® is not effective in repairing neuronal damage. Panhematin® is for intravenous use only. Dose is 1 to 4 mg/kg/day for 3-14 days based on the clinical signs. Standard dose in clinical practice is 3 to 4 mg/kg/day. Repeat dose in more severe cases no earlier than every 12 hours. Do not exceed 6 mg/kg in any 24-hour period.
Download this step-by-step guide to dosing, preparation, and infusion. Download Here